Clinical Trials Sponsored by Mark W. Dodson

Total 4 results

Mark W. Dodson

Unknown

The Prospective Risk Factor Evaluation & Discovery In CTEPH Study (PREDICT PH)

Chronic Thromboembolic Pulmonary Hypertension

United States
Lemuel W. Taylor IV
Manzo Pharmaceuticals

Unknown

Does Daily Supplementation of Lactobacillus Acidophilus MPH734, for One Week, Affect Acute (Immediate), Subacute (7 Days), and Post-treatment Discontinuation Lactose Metabolism, Gastrointestinal Symptoms, and Clinical Markers of Inflammation and Safety Compared to a Placebo (LF)

Lactose Intolerance

United States
Kuopio University Hospital
Medical University of Vienna; Rigshospitalet, Denmark; University College, London and other collaborators

Active, not recruiting

Adenovirus Vascular Endothelial Growth Factor D (AdvVEGF-D) Therapy for Treatment of Refractory Angina Pectoris (ReGenHeart)

Coronary Artery Disease | Refractory Angina Pectoris | Gene Transfer

Denmark, Finland
Queen Mary University of London
National Institute for Health Research, United Kingdom; WBIC), Cambridge. University... and other collaborators

Unknown

IS Metomidate PET-CT Superior to Adrenal Venous Sampling in Predicting Outcome From Adrenalectomy in Patients With Primary Hyperaldosteronism (MATCH)

Primary Aldosteronism | Hyperaldosteronism

United Kingdom

3

Subscribe